πŸ‡ΊπŸ‡Έ FDA
Patent

US 11980636

Treatment of hematological disorders

granted A61KA61K31/635A61K31/704

Quick answer

US patent 11980636 (Treatment of hematological disorders) held by Jazz Pharmaceuticals Ireland Limited expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jazz Pharmaceuticals Ireland Limited
Grant date
Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/635, A61K31/704, A61K31/7068, A61K9/127